Abstract
A variety of 7-[(1,5-dialkyl-1H-1,2,4-triazolyl)methoxy(and methyl)]coumarins were synthesized from cycloaddition of 2-(2H-benzopyran-7-yloxy)acetonitrile and 2-(5-methoxy-4-methyl-2H-benzopyran-7-yloxy)acetonitrile, respectively, with various reactive cumulene intermediates via spontaneous rearrangements. The anticancer (breast, lung, CNS cancers) and antiviral (HIV-1, HIV-2) properties of some compounds were investigated in vitro. 5-Methoxy-4-methyl-7-[(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[1,5-a]azepin-2-yl)methyl]coumarin showed some inhibition of HIV-1.
Similar content being viewed by others
References
C. Ito, M. Chiliro, S. Katsuno, M. Omura, H. Tokuda, H. Nishino, and H. Furukawa, J. Nat. Prod., 63, 1218 (2000).
A. Z. Abyshev, G. I. D’Yachuk, E. V. Semenov, and M. P. Pukhov, Pharm. Chem. J., 27, 66 (1993).
C. A. Kontogiorgis and D. J. Hadjipavlou, Bioorg. Med. Chem. Lett., 14, 611 (2004).
A. Z. Abyshev, A. T. Alekseev, V. G. Platonov, and I. A. Byrkin, Pharm. Chem. J., 30, 441 (1996).
C. Teran, L. Santana, E. Uriarte, Y. Fall, L. Lena, and B.-R. Tolf, Bioorg. Med. Chem. Lett., 8, 3570 (1998).
T.-C Wang, Y.-L. Chen, C.-C. Cherng, S.-S. Liou, Y.-L. Chang, and C.-M. Teng, Helv. Chim. Acta, 79, 1620 (1996).
A. M. El-Syed, A.-B. A. G. Ghattas, M. T. El-Wassimy, and O. A. Abd Allah, Farmaco, 54, 56 (1999), references therein.
M. E. Kuehne, US Pat. 3,142,676; Chem. Abstr., 61, 8319 (1964).
L. Pochet, R. Frederic, and B. Masereel, Curr. Pharm. Design, 10, 3781 (2004).
K. Padmawinata, Acta Pharm., 4, 1 (1973); Chem. Abstr., 79, 758970 (1973).
J. P. Jerris and A. B. Smith, J. Org. Chem., 46, 577 (1981).
Y.-L. Chen, T.-C. Wang, C.-C. Tzeng, and N.-C. Chang, Helv. Chim. Acta, 82, 191 (1999).
J. Hirsh, V. Fuster, J. Ansell, and L. Halperin, J. Am. College Cardiology, 41, 1633 (2003).
Y. Sato, Y. Kobayashi, T. Nagasaki, T. Oshima, S. Kumakura, K. Nakayama, H. Koike, and H. Takagi, Chem. Pharm. Bull., 20, 905 (1972).
Y.-L. Chen, T.-C. Wang, N.-C. Chang, Y.-L. Chang, C.-M. Teng, and C.-C. Tzeng, Chem. Pharm. Bull., 46, 962 (1998).
S. Cuzzocrea, E. Mazzon, C. Bevilacqua, G. Costantino, D. Britti, G. Mazzullo, A. De Sarro, and A. P. Caputi, Br. J. Pharmcacol., 131, 1399 (2000).
K. Furumi, T. Fujioka, H. Fujii, H. Okab, Y. Nakano, H. Matsunaga, M. Katano, M. Mori, and K. Mihashi, Bioorg. Med Chem. Lett., 8, 93 (1998).
P. E. Goss and K. Strasser-Weippl, Best Pract. Res. Clin. End. Met., 18, 113 (2004).
R. J. Santen, Steroids, 68, 559 (2003).
M. Clemons, R. E. Coleman, and S. Verma, Cancer Treat. Rev., 30, 325 (2004).
N. A. Al-Masoudi, N. A. Hassan, Y. A. Al-Soud, P. Schmidt, A. E-D M. Gaafer, M. Weng, S. Marino, A. Schoch, A. Amer, and J. C. Jochims, J. Chem. Soc., Perkin Trans. 1, 947 (1998).
Y. A. Al-Soud, W. A. Al-Masoudi, R. A. El-Halawa, and N. A. Al-Masoudi, Nucleosides, Nucleotides, 18, 1985 (1999).
N. A. Al-Masoudi and Y. A. Al-Soud, A. Geyer, Tetrahedron, 55, 751 (1999).
Y. A. Al-Soud and N. A. Al-Masoudi, Pharm. Pharm. Med. Chem., 332, 143 (1999).
Y. A. Al-Soud and N. A. Al-Masoudi, Pharmazie, 56, 372 (2001).
N. A. Al-Masoudi, Y. A. Al-Soud, and I. Lagoja, Carbohydr. Res., 318, 67 (1999).
Y. A. Al-Soud, and N. A. Al-Masoudi, Org. Prep. Proced. Int., 49, 658 (2002).
Y. A. Al-Soud, N. A. Al-Masoudi, and A. R. S. El-Ferawnah, Bioorg. Med. Chem., 11, 1701 (2003).
Y. A. Al-Soud and N. A. Al-Masoudi, Heteroatom Chem., 14, 298 (2003).
Y. A. Al-Soud, M. N. Al-Dweri, and N. A. Al-Masoudi, Farmaco, 59, 775 (2004).
Y. A. Al-Soud and N. A. Al-Masoudi, Farmaco, 59, 41 (2004).
Y. A. Al-Soud, M. N. A. Qalalweh, H. H. Al-Sa’doni, and N. A. Al-Masoudi; Heteroatom Chem., 16, 28 (2005).
N. A. Al-Masoudi, I. A. Al-Masoudi, I. A. I. Ali, Y. A. Al-Soud, B. Saeed, and P. La Colla, Acta Pharm., 56, 175 (2006).
A. Balbi, E. Sottofattori, T. Grandi, M. Mazzei, D. S. Pyshnyi, S. C. Lokhov, and A. V. Lebede, Bioorg. Med. Chem., 5, 1903 (1997).
Y. A. Al-Soud, W. Wirschum, N. A. Hassan, G. M. Maier, and J. C. Jochims, Synthesis, 721 (1998); references therein.
Q. Wang, J. C. Jochims, St. Kählbrandt, L. Dahlenburg, M. Al-Talib, A. Hamed, and A. E. Ismail, Synthesis, 710 (1992).
Q. Wang, M. Al-Talib, and J. C. Jochims, Chem. Ber., 127, 541 (1994).
W. Willker, D. Leibfritz, R. Kerssebaum, and W. Bermel, Magn. Res. Chem., 31, 287 (1993).
F. Eiden and P. Meins, Pharmazie, 305, 124 (1972).
A. Monks, D. Scuiero, P. Skehan, R. Shoemaker, K. Paull, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo, and M. Boyd, J. Natl. Cancer Inst., 83, 757 (1991).
G. D. Gray and E. Wickstrom, Biotechniques, 21, 780 (1996).
Author information
Authors and Affiliations
Additional information
Published in Khimiya Geterotsiklicheskikh Soedinenii, No. 5, pp. 669–678, May, 2006.
Rights and permissions
About this article
Cite this article
Al-Soud, Y.A., Al-Masoudi, I.A., Saeed, B. et al. Synthesis of new 1H-1,2,4-triazolylcoumarins and their antitumor and anti-HIV activities. Chem Heterocycl Compd 42, 583–590 (2006). https://doi.org/10.1007/s10593-006-0130-2
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10593-006-0130-2